Showing results (331-340 of 384) with videos related to
Sort By:
Pageof 39
BJU International|July 2, 2024
Association of Genomic Prostate Score at positive margin with recurrence after radical prostatectomySanaz Nourmohammadi Abadchi, Daniela C Salles, Cynthia Flannery, et al.International Journal of Surgical Pathology|April 9, 2013
Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancerNilda González-Roibón, Jeong S Han, Stephen Lee, et al.Urology|October 18, 2002
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?Yoshio Naya, Thomas A Stamey, Carol D Cheli, et al.The Journal of Urology|October 9, 2003
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trialAlan W Partin, Michael K Brawer, Georg Bartsch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2011
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patientsTamara L Lotan, Bora Gurel, Siobhan Sutcliffe, et al.The Journal of Urology|May 31, 2016
SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy CohortMichael H Johnson, Ashley E Ross, Mohammed Alshalalfa, et al.Journal of the National Cancer Institute. Monographs|June 26, 2024
A Framework for Integrating Telehealth Equitably across the cancer care continuumKatharine A Rendle, Andy S L Tan, Bonnie Spring, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasAntoun Toubaji, Roula Albadine, Alan K Meeker, et al.Stem Cells Translational Medicine|February 9, 2019
A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate CancerMichael T Schweizer, Hao Wang, Trinity J Bivalacqua, et al.Plos One|January 6, 2016
Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical ProstatectomySheila F Faraj, Stephania M Bezerra, Kasra Yousefi, et al.Pageof 39